drugset / Trial / NCT00830349

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

NCT00830349

Phase 1 Completed 30 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to compare the rate and extent of absorption of risperidone 1 mg tablets (test) versus Risperdal® (reference) administered as a 1 x 1 mg tablet under fasting conditions.

Timeline

Start
2001-06
Primary completion
2001-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Risperidone Other / unclassified 1 mg

Indications

No indication recorded.